精准给药市场－全球产业规模、份额、趋势、机会及预测，依病患类型、工具、软体、药物类别、地区及竞争格局划分，2020-2030年预测

2024年全球精准给药市场规模为1.8834亿美元，预计到2030年将以7.72%的复合年增长率增长至2.9433亿美元。精准给药是指在各种工业和医疗应用中，对物质（通常是微量物质）进行精确可控的输送。推动市场扩张的关键因素包括：电子製造业对製程优化和小型化的需求不断增长；製药和生物技术行业对品质控制的严格要求；以及各行业对自动化技术的日益普及。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：客户之声

第五章：全球精准给药市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依患者类型（儿科、老年科、多重用药患者、终末器官功能障碍患者、其他）
  • 依工具分类（基于生理的药物动力学 (PBPK) 模型、非线性混合效应 (NLME) 模型）
  • 依软体类型（基于Web、基于桌面）
  • 依药物类别（抗生素、抗霉菌药、免疫抑制剂、抗癫痫药、抗肿瘤药、抗忧郁药、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美精准给药市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲精准给药市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区精准给药市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲精准给药市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲精准给药市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球精准给药市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• InsightRX Inc.
• Tabula Rasa HealthCare, Inc.
• Healthware, Inc. (PrecisePK)
• Vesynta Limited
• Oxular Limited
• Accent Therapeutics, Inc.
• Rapport Therapeutics, Inc.
• HNP Mikrosysteme GmbH
• Fluid-O-Tech Srl
• Psycheceutical, Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Precision Dosing Market, valued at USD 188.34 Million in 2024, is projected to experience a CAGR of 7.72% to reach USD 294.33 Million by 2030. Precision dosing involves the accurate and controlled delivery of substances, often in minute quantities, across diverse industrial and medical applications. Key drivers supporting market expansion include the increasing demand for process optimization and miniaturization in electronics manufacturing, stringent quality control requirements in the pharmaceutical and biotech sectors, and the growing adoption of automation technologies across various industries.

Key Market Drivers

The Global Precision Dosing Market is significantly propelled by advancements in pharmacogenomics and genetic profiling. These scientific developments enable a more profound understanding of individual patient responses to medications by analyzing genetic variations that influence drug metabolism, efficacy, and safety. Such insights are fundamental to tailoring therapeutic regimens with unprecedented accuracy, moving away from generalized treatment protocols. For instance, in an article published in *The Pharmacogenomics Journal*, October 2024, a pharmacogenomics-enriched comprehensive medication management program was associated with 39% fewer inpatient and 39% fewer emergency department visits, highlighting the clinical utility and direct benefits of genetically guided dosing. This precision minimizes adverse drug reactions and optimizes therapeutic outcomes, fostering greater confidence in individualized treatments.

Key Market Challenges

High initial capital expenditure presents a significant impediment to the expansion of the Global Precision Dosing Market. The substantial upfront investment required for advanced precision dosing systems directly limits their adoption, particularly among smaller enterprises or those operating with constrained capital budgets. This financial barrier delays the integration of such technologies, even when their long-term benefits in terms of efficiency and quality are evident.

Key Market Trends

The strategic integration of artificial intelligence and machine learning into dosing protocols is a pivotal trend transforming the Global Precision Dosing Market. These advanced technologies enhance the accuracy and efficiency of drug administration by analyzing vast datasets to predict optimal dosages, identify patient-specific responses, and refine treatment regimens. According to the US Food and Drug Administration's (FDA) Division of Pharmaceutical Manufacturing Assessment III, in a June 2024 address, approximately 40% of companies are already utilizing AI in various capacities within pharmaceutical manufacturing, indicating a significant move towards intelligent systems for production and delivery. This adoption extends to precision dosing, where AI-driven models can continuously learn and adapt, leading to improved therapeutic outcomes.

Key Market Players

• InsightRX Inc.
• Tabula Rasa HealthCare, Inc.
• Healthware, Inc. (PrecisePK)
• Vesynta Limited
• Oxular Limited
• Accent Therapeutics, Inc.
• Rapport Therapeutics, Inc.
• HNP Mikrosysteme GmbH
• Fluid-O-Tech Srl
• Psycheceutical, Inc.

Report Scope:

In this report, the Global Precision Dosing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Precision Dosing Market, By Patient Type:

• Paediatrics
• Geriatrics
• Patients on Polypharmacy
• Patients with End Organ Dysfunction
• Others

Precision Dosing Market, By Tools:

• Physiologically Based Pharmacokinetic (PBPK) Modeling
• Non-Linear Mixed Effects (NLME) Modeling

Precision Dosing Market, By Software:

• Web-Based
• Desktop-Based

Precision Dosing Market, By Drug Class:

• Antibiotics
• Antimycotics
• Immunosuppressives
• Antiepileptics
• Antitumoral Drugs
• Antidepressants
• Others

Precision Dosing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Precision Dosing Market.

Available Customizations:

Global Precision Dosing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Precision Dosing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Patient Type (Paediatrics, Geriatrics, Patients on Polypharmacy, Patients with End Organ Dysfunction, Others)
  • 5.2.2. By Tools (Physiologically Based Pharmacokinetic (PBPK) Modeling, Non-Linear Mixed Effects (NLME) Modeling)
  • 5.2.3. By Software (Web-Based, Desktop-Based)
  • 5.2.4. By Drug Class (Antibiotics, Antimycotics, Immunosuppressives, Antiepileptics, Antitumoral Drugs, Antidepressants, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Precision Dosing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Patient Type
  • 6.2.2. By Tools
  • 6.2.3. By Software
  • 6.2.4. By Drug Class
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Precision Dosing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Patient Type
      • 6.3.1.2.2. By Tools
      • 6.3.1.2.3. By Software
      • 6.3.1.2.4. By Drug Class
  • 6.3.2. Canada Precision Dosing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Patient Type
      • 6.3.2.2.2. By Tools
      • 6.3.2.2.3. By Software
      • 6.3.2.2.4. By Drug Class
  • 6.3.3. Mexico Precision Dosing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Patient Type
      • 6.3.3.2.2. By Tools
      • 6.3.3.2.3. By Software
      • 6.3.3.2.4. By Drug Class

7. Europe Precision Dosing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Patient Type
  • 7.2.2. By Tools
  • 7.2.3. By Software
  • 7.2.4. By Drug Class
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Precision Dosing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Patient Type
      • 7.3.1.2.2. By Tools
      • 7.3.1.2.3. By Software
      • 7.3.1.2.4. By Drug Class
  • 7.3.2. France Precision Dosing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Patient Type
      • 7.3.2.2.2. By Tools
      • 7.3.2.2.3. By Software
      • 7.3.2.2.4. By Drug Class
  • 7.3.3. United Kingdom Precision Dosing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Patient Type
      • 7.3.3.2.2. By Tools
      • 7.3.3.2.3. By Software
      • 7.3.3.2.4. By Drug Class
  • 7.3.4. Italy Precision Dosing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Patient Type
      • 7.3.4.2.2. By Tools
      • 7.3.4.2.3. By Software
      • 7.3.4.2.4. By Drug Class
  • 7.3.5. Spain Precision Dosing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Patient Type
      • 7.3.5.2.2. By Tools
      • 7.3.5.2.3. By Software
      • 7.3.5.2.4. By Drug Class

8. Asia Pacific Precision Dosing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Patient Type
  • 8.2.2. By Tools
  • 8.2.3. By Software
  • 8.2.4. By Drug Class
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Precision Dosing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Patient Type
      • 8.3.1.2.2. By Tools
      • 8.3.1.2.3. By Software
      • 8.3.1.2.4. By Drug Class
  • 8.3.2. India Precision Dosing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Patient Type
      • 8.3.2.2.2. By Tools
      • 8.3.2.2.3. By Software
      • 8.3.2.2.4. By Drug Class
  • 8.3.3. Japan Precision Dosing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Patient Type
      • 8.3.3.2.2. By Tools
      • 8.3.3.2.3. By Software
      • 8.3.3.2.4. By Drug Class
  • 8.3.4. South Korea Precision Dosing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Patient Type
      • 8.3.4.2.2. By Tools
      • 8.3.4.2.3. By Software
      • 8.3.4.2.4. By Drug Class
  • 8.3.5. Australia Precision Dosing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Patient Type
      • 8.3.5.2.2. By Tools
      • 8.3.5.2.3. By Software
      • 8.3.5.2.4. By Drug Class

9. Middle East & Africa Precision Dosing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Patient Type
  • 9.2.2. By Tools
  • 9.2.3. By Software
  • 9.2.4. By Drug Class
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Precision Dosing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Patient Type
      • 9.3.1.2.2. By Tools
      • 9.3.1.2.3. By Software
      • 9.3.1.2.4. By Drug Class
  • 9.3.2. UAE Precision Dosing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Patient Type
      • 9.3.2.2.2. By Tools
      • 9.3.2.2.3. By Software
      • 9.3.2.2.4. By Drug Class
  • 9.3.3. South Africa Precision Dosing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Patient Type
      • 9.3.3.2.2. By Tools
      • 9.3.3.2.3. By Software
      • 9.3.3.2.4. By Drug Class

10. South America Precision Dosing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Patient Type
  • 10.2.2. By Tools
  • 10.2.3. By Software
  • 10.2.4. By Drug Class
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Precision Dosing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Patient Type
      • 10.3.1.2.2. By Tools
      • 10.3.1.2.3. By Software
      • 10.3.1.2.4. By Drug Class
  • 10.3.2. Colombia Precision Dosing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Patient Type
      • 10.3.2.2.2. By Tools
      • 10.3.2.2.3. By Software
      • 10.3.2.2.4. By Drug Class
  • 10.3.3. Argentina Precision Dosing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Patient Type
      • 10.3.3.2.2. By Tools
      • 10.3.3.2.3. By Software
      • 10.3.3.2.4. By Drug Class

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Precision Dosing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. InsightRX Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Tabula Rasa HealthCare, Inc.
• 15.3. Healthware, Inc. (PrecisePK)
• 15.4. Vesynta Limited
• 15.5. Oxular Limited
• 15.6. Accent Therapeutics, Inc.
• 15.7. Rapport Therapeutics, Inc.
• 15.8. HNP Mikrosysteme GmbH
• 15.9. Fluid-O-Tech Srl
• 15.10. Psycheceutical, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer